Pituitary stalk meningioma

disease
On this page

Also known as meningioma (disease) of pituitary stalkmeningioma of pituitary stalkmeningioma of the pituitary stalkpituitary stalk meningioma (disease)

Summary

Pituitary stalk meningioma (MONDO:0004447) is a disease. A subtype of anterior cranial fossa meningioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namepituitary stalk meningioma
Mondo IDMONDO:0004447
DOIDDOID:8058
NCITC5311
UMLSC1335422
MedGen233858
GARD0024010
Anatomy (UBERON)UBERON:0002434
Is cancer (heuristic)no

Also known as: meningioma (disease) of pituitary stalk · meningioma of pituitary stalk · meningioma of the pituitary stalk · pituitary stalk meningioma (disease)

Disease family

This is a subtype of anterior cranial fossa meningioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorderskeletal system disorderanterior cranial fossa meningiomapituitary stalk meningioma

Related subtypes (2): cerebral falx meningioma, olfactory groove meningioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.